SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022727
Filing Date
2017-11-08
Accepted
2017-11-08 16:07:19
Documents
65
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akba-10q_20170930.htm 10-Q 1904575
2 EX-10.1 akba-ex101_154.htm EX-10.1 46676
3 EX-31.1 akba-ex311_12.htm EX-31.1 17377
4 EX-31.2 akba-ex312_10.htm EX-31.2 17393
5 EX-32.1 akba-ex321_6.htm EX-32.1 11888
6 EX-99.1 akba-ex991_8.htm EX-99.1 82710
7 GRAPHIC g20171108134205989972.jpg GRAPHIC 631
8 GRAPHIC g20171108134205712971.jpg GRAPHIC 2066
  Complete submission text file 0001564590-17-022727.txt   7805377

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT akba-20170930.xml EX-101.INS 1815077
10 XBRL TAXONOMY EXTENSION SCHEMA akba-20170930.xsd EX-101.SCH 56881
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akba-20170930_cal.xml EX-101.CAL 56624
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akba-20170930_def.xml EX-101.DEF 193248
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE akba-20170930_lab.xml EX-101.LAB 401182
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akba-20170930_pre.xml EX-101.PRE 308868
Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 171186647
SIC: 2834 Pharmaceutical Preparations